RECLAST (also known as Zoledronic Acid)

Mechanism:

Reclast, a potent medication in the bisphosphonate class, reduces bone resorption and turnover and results in a net gain in bone mass.

Indications:

• Treatment & prevention of postmenopausal osteoporosis
• Treatment to increase bone mass in men with osteoporosis
• Treatment and prevention of glucocorticoid-induced osteoporosis
• Treatment of Paget’s disease of bone in men and women.

Contraindications:

Patients with hypocalcemia and renal impairment should consult with their physicians prior to starting Reclast.

Administration:

Reclast is typically administered as infusion over 15 minutes every 1-2 years for osteoporosis.